Robert W. Rees
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Small Animals top 5%
- Animal testing and alternatives
Papers in ⓘ
-
- Carcinogens and Genotoxicity Assessment 11
-
- bioluminescence and chemiluminescence research 2
- Insect Resistance and Genetics 2
- Co-authors
- Richard M. Walmsley (4 shared papers)Paul W. Hastwell (4 shared papers)James Harvey (2 shared papers)Kevin J. Roberts (1 shared paper)Anthony M. Lynch (7 shared papers)Jennifer Southgate (2 shared papers)Nicholas Billinton (3 shared papers)Nicola J. MacLaine (1 shared paper)
- Journals
- Mutation Research/Genetic Toxicology and Environmental Mutagenesis (6 papers)Mutagenesis (5 papers)Molecular Cancer Research (1 paper)Environmental and Molecular Mutagenesis (1 paper)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Robert W. Rees
17 papers receiving 329 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 192
- Small Animals 77
- Chemical Health and Safety 6
- Health, Toxicology and Mutagenesis 95
- Pharmacology 23
Countries citing papers authored by Robert W. Rees
This map shows the geographic impact of Robert W. Rees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Rees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Rees more than expected).
Fields of papers citing papers by Robert W. Rees
This network shows the impact of papers produced by Robert W. Rees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Rees. The network helps show where Robert W. Rees may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. Rees, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 118 | |
| 2 | 2009 | 36 | |
| 3 | 2007 | 27 | |
| 4 | 2008 | 27 | |
| 5 | 1999 | 25 | |
| 6 | 2008 | 23 | |
| 7 | 2008 | 18 | |
| 8 | 2008 | 14 | |
| 9 | 2010 | 12 | |
| 10 | 1989 | 8 | |
| 11 | 1990 | 8 | |
| 12 | 1994 | 7 | |
| 13 | 2009 | 6 | |
| 14 | 2002 | 5 | |
| 15 | 2008 | 4 | |
| 16 | 1982 | 3 | |
| 17 | Investigations into the lymphopaenic and immunosuppressive properties of the antitumour agent, mitoclomine. | 1971 | 2 |
About Robert W. Rees
Robert W. Rees is a scholar working on Cancer Research, Molecular Biology, Small Animals, Health, Toxicology and Mutagenesis and Plant Science, having authored 17 papers that have together received 343 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (11 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Animal testing and alternatives (5 papers), Computational Drug Discovery Methods (2 papers), Genetically Modified Organisms Research (2 papers), bioluminescence and chemiluminescence research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Insect Resistance and Genetics (2 papers). The work is most often cited by research in Cancer Research (192 citations), Small Animals (77 citations), Chemical Health and Safety (6 citations), Health, Toxicology and Mutagenesis (95 citations) and Pharmacology (23 citations). Robert W. Rees has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Richard M. Walmsley, Paul W. Hastwell, James Harvey, Kevin J. Roberts, Anthony M. Lynch, Jennifer Southgate, Nicholas Billinton, Nicola J. MacLaine, Matthew Tate and Julie C. Holder. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Mutagenesis, Molecular Cancer Research, Environmental and Molecular Mutagenesis and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.